Christopher J. DeRespino
No más puestos en curso
Perfil
Christopher J.
DeRespino worked as an Executive Director of Business Development at Amgen, Inc. from 2018 to 2021.
Prior to that, he worked as a Director of Business Development at Onyx Pharmaceuticals, Inc. He also briefly served as the Chief Financial, Accounting & Business Officer at Adverum Biotechnologies, Inc. in 2021.
DeRespino received his undergraduate degree from The Johns Hopkins University and his MBA from The Leonard N Stern School of Business.
Antiguos cargos conocidos de Christopher J. DeRespino.
Empresas | Cargo | Fin |
---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Director of Finance/CFO | 27/08/2021 |
AMGEN INC. | Corporate Officer/Principal | 01/02/2021 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Formación de Christopher J. DeRespino.
The Johns Hopkins University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
AMGEN INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher J. DeRespino